Fidelis Insurance (NYSE:FIHL - Get Free Report) had its price objective cut by Barclays from $20.00 to $18.00 in a report issued on Thursday,Benzinga reports. The firm currently has an "equal weight" rating on the stock. Barclays's target price points to a potential upside of 24.14% from the company's previous close.
Other equities research analysts have also issued research reports about the stock. JPMorgan Chase & Co. decreased their price target on shares of Fidelis Insurance from $21.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, January 3rd. Keefe, Bruyette & Woods reduced their price objective on shares of Fidelis Insurance from $26.00 to $25.00 and set an "outperform" rating for the company in a research note on Friday, January 10th. Finally, The Goldman Sachs Group reiterated a "sell" rating and issued a $16.00 price objective (down from $21.00) on shares of Fidelis Insurance in a research note on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, Fidelis Insurance has an average rating of "Hold" and a consensus target price of $20.29.
Get Our Latest Stock Analysis on Fidelis Insurance
Fidelis Insurance Stock Performance
Shares of FIHL stock traded down $0.86 during trading hours on Thursday, hitting $14.50. 811,647 shares of the company were exchanged, compared to its average volume of 577,481. The firm has a fifty day simple moving average of $16.90 and a 200 day simple moving average of $17.90. The company has a current ratio of 0.68, a quick ratio of 0.68 and a debt-to-equity ratio of 0.17. Fidelis Insurance has a 52-week low of $13.28 and a 52-week high of $21.32. The stock has a market capitalization of $1.71 billion, a price-to-earnings ratio of 3.66 and a beta of 0.48.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the company. R Squared Ltd bought a new position in Fidelis Insurance in the 4th quarter valued at $26,000. Venturi Wealth Management LLC boosted its holdings in Fidelis Insurance by 1,862.9% in the 4th quarter. Venturi Wealth Management LLC now owns 6,144 shares of the company's stock valued at $111,000 after purchasing an additional 5,831 shares during the period. Y Intercept Hong Kong Ltd bought a new position in Fidelis Insurance in the 3rd quarter valued at $195,000. Fox Run Management L.L.C. bought a new position in Fidelis Insurance in the 4th quarter valued at $235,000. Finally, Summit Global Investments bought a new position in Fidelis Insurance in the 3rd quarter valued at $238,000. 81.99% of the stock is owned by institutional investors.
About Fidelis Insurance
(
Get Free Report)
Fidelis Insurance Holdings Limited, a specialty insurer, provides insurance and reinsurance solutions in Bermuda, the Republic of Ireland, and the United Kingdom. It operates in three segments: Specialty, Reinsurance, and Bespoke segments. The Specialty segment offers aviation and aerospace, energy, marine, property direct and facultative, and other specialty risk solutions.
See Also

Before you consider Fidelis Insurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fidelis Insurance wasn't on the list.
While Fidelis Insurance currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.